Physician profile
Megan L Childers
NPI 1619217106
$9,653.40
in general payments reported to CMS, 2019-2025
54 companies · $2,754 in 2025
The $2,754 reported for 2025 was more than what 95% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $1,757 · 2023: $1,650 · 2024: $3,334 · 2025: $2,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,597 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,596.85 |
| Education | $141.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,002.53 | 2022-2025 | |
| Eisai INC. | $607.71 | 2022-2025 | |
| Lilly USA, LLC | $551.45 | 2022-2025 | Kisunla, Amyvid, Emgality |
| Pfizer INC. | $501.94 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $489.73 | 2022-2025 | Ultomiris, Soliris, Strensiq |
| Emd Serono, INC. | $464.01 | 2022-2025 | Mavenclad |
| Boston Scientific Corporation | $435.75 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $383.40 | 2022-2025 | |
| Sk Life Science, INC. | $372.82 | 2022-2025 | |
| Neurelis, INC. | $348.06 | 2023-2025 | Valtoco |
| Argenx US, INC. | $330.09 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $305.45 | 2022-2025 | Vyepti, Rexulti |
| Ani Pharmaceuticals, INC. | $300.82 | 2023-2025 | Purified Cortrophin Gel |
| Ucb, INC. | $253.23 | 2023-2025 | Rystiggo, Briviact, Fintepla |
| Biohaven Pharmaceutical Holding Company Ltd. | $244.46 | 2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $237.10 | 2023-2025 | Vumerity, Avonex, Plegridy |
| Neurocrine Biosciences, INC. | $223.67 | 2022-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $203.76 | 2022-2025 | Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $195.38 | 2023-2025 | Rexulti, Nuedexta |
| Mallinckrodt Hospital Products INC. | $170.94 | 2022-2025 | Acthar |
| Genentech USA, INC. | $149.37 | 2022-2025 | Ocrevus Zunovo |
| Amneal Pharmaceuticals LLC | $145.35 | 2022-2025 | Brekiya, Crexont, Rytary |
| Jazz Pharmaceuticals INC. | $141.51 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $140.23 | 2022-2024 | Nuplazid |
| Abbott Laboratories | $119.98 | 2022 | |
| Tg Therapeutics, INC. | $114.74 | 2024-2025 | |
| Impel Pharmaceuticals INC. | $99.21 | 2023 | Trudhesa |
| Amgen INC. | $98.84 | 2023-2024 | Uplizna, Aimovig |
| Axsome Therapeutics, INC. | $82.68 | 2024-2025 | Symbravo, Sunosi |
| Cycle Pharmaceuticals INC | $78.10 | 2024-2025 | Tascenso Odt, Bafiertam |
| Genzyme Corporation | $75.80 | 2022-2025 | |
| Celgene Corporation | $73.79 | 2022-2025 | Zeposia |
| Sumitomo Pharma America, INC. | $68.27 | 2023 | Aptiom |
| Medtronic, INC. | $65.64 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Scilex Pharmaceuticals INC. | $52.41 | 2023-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.60 | 2022 | |
| Kyowa Kirin, INC. | $43.73 | 2024 | Nourianz |
| Allergan, INC. | $38.47 | 2021-2022 | |
| Catalyst Pharmaceuticals, INC. | $38.20 | 2022-2024 | |
| Vanda Pharmaceuticals INC. | $38.07 | 2025 | Ponvory |
| Upsher-Smith Laboratories LLC | $37.16 | 2022 | |
| Hikma Pharmaceuticals USA | $32.46 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $28.70 | 2024-2025 | Keveyis |
| Octapharma USA, INC. | $27.86 | 2024 | Panzyga |
| Takeda Pharmaceuticals U.S.A., INC. | $27.77 | 2023 | |
| Impel Pharmaceuticals LLC | $24.48 | 2025 | Trudhesa |
| Alnylam Pharmaceuticals INC. | $22.04 | 2024 | Onpattro |
| Banner Life Sciences, LLC | $21.58 | 2023 | |
| Harmony Biosciences LLC | $19.73 | 2024 | |
| Tonix Medicines, INC. | $17.90 | 2025 | Tonmya |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $17.34 | 2024 | |
| Kedrion Biopharma, INC. | $16.20 | 2025 | Gammaked, Kedrab, Koate |
| Janssen Biotech, INC. | $15.43 | 2025 | |
| Arbor Pharmaceuticals, INC. | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Childers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.